Literature DB >> 2865274

Rates of noninsulin-mediated glucose uptake are elevated in type II diabetic subjects.

A D Baron, O G Kolterman, J Bell, L J Mandarino, J M Olefsky.   

Abstract

Although insulin is extremely potent in regulating glucose transport in insulin-sensitive tissues, all tissues are capable of taking up glucose by facilitated diffusion by means of a noninsulin-mediated glucose uptake (NIMGU) system. Several reports have estimated that in the postabsorptive state the majority of glucose disposal occurs via a NIMGU mechanism. However, these estimates have been either derived or extrapolated in normal humans. In the present study we have directly measured NIMGU rates in 11 normal (C) and 7 Type II noninsulin-dependent diabetic subjects (NIDDM; mean +/- SE fasting serum glucose, 249 +/- 24 mg/dl). To accomplish this, the serum glucose was clamped at a desired level during a period of insulin deficiency induced by a somatostatin infusion (SRIF, 550 micrograms/h). With a concomitant [3-3H]glucose infusion, we could isotopically quantitate glucose disposal rates (Rd) during basal (basal insulin present) and insulin-deficient (SRIF) conditions. With this approach we found that (a) basal Rd was greater in NIDDM than in C, 274 +/- 31 vs. 150 +/- 7 mg/min, due to elevated hepatic glucose output, (b) NIMGU composes 75 +/- 5% of basal Rd in C and 71 +/- 4% in NIDDM, (c) NIDDMS have absolute basal NIMGU rates that are twice that of C (195 +/- 23 vs. 113 +/- 8 mg/min, P less than 0.05), (d) when C were studied under conditions of insulin deficiency (SRIF infusion) and at a serum glucose level comparable to that of the NIDDM group (250 mg/dl), their rates of NIMGU were the same as that of the NIDDM group (186 +/- 19 vs. 195 +/- 23 mg/min; NS). We conclude that (a) in the postabsorptive state, NIMGU is the major pathway for glucose disposal for both C and NIDDM; (b) for a given glucose level the efficiency of NIMGU (NIMGU divided by serum glucose level) is equal in C and NIDDM, but since basal Rd is elevated in NIDDMs their absolute basal rates of NIMGU are higher; and (c) elevated basal rates of NIMGU in NIDDM may play a role in the pathogenesis of the late complications of diabetes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2865274      PMCID: PMC424207          DOI: 10.1172/JCI112169

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  22 in total

1.  OBSERVATIONS ON CEREBRAL CARBOHYDRATE METABOLISM IN MAN.

Authors:  P SCHEINBERG
Journal:  Ann Intern Med       Date:  1965-02       Impact factor: 25.391

2.  Influences of glucose loading and of injected insulin on hepatic glucose output.

Authors:  R STEELE
Journal:  Ann N Y Acad Sci       Date:  1959-09-25       Impact factor: 5.691

3.  Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays.

Authors:  B Desbuquois; G D Aurbach
Journal:  J Clin Endocrinol Metab       Date:  1971-11       Impact factor: 5.958

4.  Brain metabolism during fasting.

Authors:  O E Owen; A P Morgan; H G Kemp; J M Sullivan; M G Herrera; G F Cahill
Journal:  J Clin Invest       Date:  1967-10       Impact factor: 14.808

5.  Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects.

Authors:  C Bogardus; S Lillioja; B V Howard; G Reaven; D Mott
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

6.  Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin.

Authors:  J E Gerich; M Lorenzi; D M Bier; E Tsalikian; V Schneider; J H Karam; P H Forsham
Journal:  J Clin Invest       Date:  1976-04       Impact factor: 14.808

7.  Extrapancreatic effect of somatostatin infusion to increase glucose clearance.

Authors:  R N Bergman; M Ader; D T Finegood; G Pacini
Journal:  Am J Physiol       Date:  1984-09

8.  Influence of hyperglycemia on insulin's in vivo effects in type II diabetes.

Authors:  R R Revers; R Fink; J Griffin; J M Olefsky; O G Kolterman
Journal:  J Clin Invest       Date:  1984-03       Impact factor: 14.808

9.  Effect of fatty acids on glucose production and utilization in man.

Authors:  E Ferrannini; E J Barrett; S Bevilacqua; R A DeFronzo
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

10.  Metabolism of C-peptide in the dog. In vivo demonstration of the absence of hepatic extraction.

Authors:  K Polonsky; J Jaspan; W Pugh; D Cohen; M Schneider; T Schwartz; A R Moossa; H Tager; A H Rubenstein
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808

View more
  21 in total

1.  Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation.

Authors:  H O Steinberg; M Tarshoby; R Monestel; G Hook; J Cronin; A Johnson; B Bayazeed; A D Baron
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

2.  Fatty acids increase glucose uptake and metabolism in C2C12 myoblasts stably transfected with human lipoprotein lipase.

Authors:  Warren H Capell; Isabel R Schlaepfer; Pamela Wolfe; Peter A Watson; Daniel H Bessesen; Michael J Pagliassotti; Robert H Eckel
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-07-13       Impact factor: 4.310

3.  Derivation of a quantitative measure of insulin sensitivity from the intravenous tolbutamide test using the minimal model of glucose dynamics.

Authors:  L L Ng; T D Hockaday
Journal:  Diabetologia       Date:  1987-09       Impact factor: 10.122

Review 4.  Metabolism of energy-yielding substrates in patients with liver cirrhosis.

Authors:  M J Müller; K H Böker; O Selberg
Journal:  Clin Investig       Date:  1994-08

5.  Reduced capacity and affinity of skeletal muscle for insulin-mediated glucose uptake in noninsulin-dependent diabetic subjects. Effects of insulin therapy.

Authors:  A D Baron; M Laakso; G Brechtel; S V Edelman
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

6.  Intravenous glucose suppresses glucose production but not proteolysis in extremely premature newborns.

Authors:  D E Hertz; C A Karn; Y M Liu; E A Liechty; S C Denne
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

7.  In vivo kinetics of insulin action on peripheral glucose disposal and hepatic glucose output in normal and obese subjects.

Authors:  R Prager; P Wallace; J M Olefsky
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

8.  Increased glucose effectiveness in normoglycemic but insulin-resistant relatives of patients with non-insulin-dependent diabetes mellitus. A novel compensatory mechanism.

Authors:  J E Henriksen; F Alford; A Handberg; A Vaag; G M Ward; A Kalfas; H Beck-Nielsen
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

9.  Predominant role of gluconeogenesis in the hepatic glycogen repletion of diabetic rats.

Authors:  A Giaccari; L Rossetti
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

10.  Effects of aging on glucose-mediated glucose disposal and glucose transport.

Authors:  R I Fink; P Wallace; J M Olefsky
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.